MAPT and Alzheimer disease: On the other hand, other transgenic mouse models of AD, such as Tg2576, P301L, or P301s tau, fail to show an increase in CRMP2 phosphorylation, suggesting that the combination of AβPP and PSEN1 mutation may be a prerequisite for dysfunctional CRMP2 phosphorylation.